OpenAlex
PricingAboutJobs
Log inGet started
Work

Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo‐controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)

HTML

Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Obesity
DOI: 10.1038/oby.2009.155
Authors: Peter Kopelman, H. Gerrit de Groot, Aila Rissanen, Stephan Rossner, Soren Toubro, Richard Palmer, Rob Hallam, Andrew Bryson, Roger I. Hickling
Institutions: St George's, University of London, Nederlandse Obesitas Kliniek, Karolinska University Hospital, Hvidovre Hospital, Alizyme PLC (United Kingdom)
Language: English

Topic: Pharmacology and Obesity Treatment
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: orlistat, type 2 diabetes, weight loss, HbA1c, glycemic control, metformin, gastrointestinal adverse effects, drug tolerability, lipase inhibitors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2154256486
FWCI: 4.994
Cites: 21
Cited by: 111
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security